Meet the expert webinar
Uncovering New Rare Disease Patients Using Structured and Unstructured Real-World Data
Webinar available on May 8, 2025 | 1:00pm EDT
Without structured real-world data (RWD) that can reliably indicate disease presence, it’s difficult for pharma companies to accurately discern rare disease patient populations and commercialize therapies to serve them. MMIT, using NorstellaLinQ, pharma’s first fully linked and integrated data asset, helped solve this challenge by integrating U.S. open claims, closed claims, labs, and unstructured EMR clinical notes.